Supplementary Materials

Supplementary Material for:

Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia

Gemma Llovera, Kerstin Hofmann, Stefan Roth, Angelica Salas-Pérdomo, Maura Ferrer-Ferrer, Carlo Perego, Elisa R. Zanier, Uta Mamrak, Andre Rex, Hélène Party, Véronique Agin, Claudine Fauchon, Cyrille Orset, Benoît Haelewyn, Maria-Grazia De Simoni, Ulrich Dirnagl, Ulrike Grittner, Anna M. Planas, Nikolaus Plesnila, Denis Vivien, Arthur Liesz*

*Corresponding author. E-mail: arthur.liesz{at}

Published 5 August 2015, Sci. Transl. Med. 7, 299ra121 (2015)
DOI: 10.1126/scitranslmed.aaa9853

This PDF file includes:

  • Fig. S1. Analyses for interrater concordance.
  • Fig. S2. Behavioral tests before and after cMCAO.
  • Fig. S3. Composite Neuroscore for functional deficits after fMCAO.
  • Fig. S4. Mortality after cMCAO and fMCAO.
  • Fig. S5. Physiological parameter analysis after cMCAO and fMCAO.
  • Fig. S6. Study protocol.
  • Fig. S7. The ARRIVE guidelines checklist.
  • Table S1. Study costs (in euro).
  • Table S2. fMCAO and cMCAO means and CIs.

[Download PDF]